ArticleBMC pulmonary medicine2025
The diagnostic contribution of bronchoalveolar lavage to lung cryo-transbronchial biopsy in interstitial lung diseases.
Article in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn interstitial lung diseases (ILDs), achieving a definitive diagnosis based on clinical and radiological findings alone can be challenging, often necessitating lung biopsy. Considering the high risk of complications associated with surgical biopsy, transbronchial cryobiopsy (c-TBB) has emerged as a less invasive alternative. However, due to its more limited histopathological yield compared to surgical biopsy, additional diagnostic methods may be required. In this study, we aimed to evaluate the diagnostic contribution of bronchoalveolar lavage (BAL) performed simultaneously with c-TBB. MATERIALS AND
methodsThis retrospective, cross-sectional study was conducted at a tertiary training and research hospital between November 2023 and June 2024. A total of 127 patients with a preliminary diagnosis of ILD who underwent simultaneous diagnostic BAL and c-TBB were included. Patients’ clinical and radiological features, BAL and c-TBB findings, and any complications were recorded. Final diagnoses for all cases were established through multidisciplinary discussion (MDD).
resultsOf the included patients, 51.2% (n = 65) were male, with a mean age of 60 years (range: 19–79). Histopathological diagnosis was achieved with c-TBB in 76.4% of cases (n = 97), with the most common diagnoses being fibrotic NSIP (31.5%, n = 40) and non-fibrotic NSIP (12.6%, n = 16). Among 30 patients without a definitive diagnosis by c-TBB, 22 received a diagnosis through MDD. The contribution rate of BAL in patients with a histopathological diagnosis was 30.9% (n = 30), and 46.6% (n = 14) in those without a histopathological diagnosis. Overall, BAL contributed to the multidisciplinary diagnosis in 34.6% of all patients (n = 44), with a statistically significant difference between groups (p = 0.04); the highest contribution was observed in the non-fibrotic HP group (p = 0.01). In cases without a histopathological diagnosis, BAL provided the highest contribution in the fibrotic HP group. No adverse events related to BAL were observed, while complications occurred in 42.5% of patients undergoing c-TBB. The most common complications were hemorrhage (mostly mild to moderate), pneumothorax (17.3%, with tube thoracostomy performed in 11.8% of all cases), and mild respiratory failure (6.3%), with no life-threatening complications recorded.
conclusionOur study demonstrates that the combined use of BAL and c-TBB provides significant added value to the multidisciplinary diagnostic process in ILDs. Performing simultaneous BAL in patients undergoing c-TBB can be considered a safe and effective approach that enhances diagnostic yield in the multidisciplinary evaluation of ILDs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.